Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group (Q74590600)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 1999

Language	Label	Description	Also known as
English	Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group	scientific article published on 01 March 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

based on heuristic

inferred from title

author name string

J M FitzGerald

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

K R Chapman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

G Della Cioppa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D Stubbing

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M S Fairbarn

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M D Till

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Brambilla

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

The Journal of Allergy and Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

3 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

427-435

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (2). Why beta-agonists should not be used regularly

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of beta 2 agonists in asthma: much ado about nothing? Still cause for concern

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma and the beta agonist debate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular vs as-needed inhaled salbutamol in asthma control

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-adrenergic bronchodilators

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The beta-agonist dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect on airway responsiveness of six weeks treatment with salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of asthma: a summary. British Thoracic Society and others

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchial reactivity to inhaled histamine: a method and clinical survey

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reproducibility and comparison of responses to inhaled histamine and methacholine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of histamine PC20. Comparison of linear and logarithmic interpolation.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (1). Beta-agonists can be used safely and beneficially in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled beta 2-agonists in the treatment of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma control during and after cessation of regular beta 2-agonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970467-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0091-6749(99)70467-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10069876%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74590600&oldid=1748169803"